Angiochem Inc

Angiochem Inc., a Quebec entity, is in active Division I proposal proceedings under the Bankruptcy and Insolvency Act. The Form 78 statement of affairs, as declared and estimated as at December 19, 2024, put total assets at $4.00 against total liabilities of $4,309,157.34 — $4.00 secured, no preferred, and $4,309,153.34 unsecured — for a declared deficit of $4,309,153.34, with subscribed and paid-up capital of $55,571,475.00 shown separately and excluded from assets. The list of creditors as of the same date shows Investissement Québec as secured for $1,599,511.00. Unsecured claims run from $58.41 owed to UPS Canada to $600,000.00 owed to JBH Consulting Sàrl, followed by Cenexi-Laboratoires Thissen at $490,133.34, Osler, Hoskin & Harcourt LLP at $229,561.72 and Piramal Pharma Solutions Inc. at $219,606.61.